These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22485003)

  • 1. Immunogenicity of two adjuvant formulations of an inactivated African horse sickness vaccine in guinea-pigs and target animals.
    Ronchi GF; Ulisse S; Rossi E; Franchi P; Armillotta G; Capista S; Peccio A; Di Ventura M; Pini A
    Vet Ital; 2012; 48(1):55-76. PubMed ID: 22485003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: evaluation of efficacy in horses and guinea-pig model.
    Lelli R; Molini U; Ronchi GF; Rossi E; Franchi P; Ulisse S; Armillotta G; Capista S; Khaiseb S; Di Ventura M; Pini A
    Vet Ital; 2013; 49(1):89-98. PubMed ID: 23564590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
    Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
    Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral antibody response of 10 horses after vaccination against African horse sickness with an inactivated vaccine containing all 9 serotypes in one injection.
    Wernery U; Rodriguez M; Raghavan R; Syriac G; Miriam Thomas M S; Elizabeth SK; Federico Ronchi G; Muhammed R; Patteril NA; Joseph S
    Equine Vet J; 2021 Jul; 53(4):826-833. PubMed ID: 33011979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of horses to inactivated African horse sickness vaccines.
    Rodríguez M; Joseph S; Pfeffer M; Raghavan R; Wernery U
    BMC Vet Res; 2020 Sep; 16(1):322. PubMed ID: 32873300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.
    von Teichman BF; Dungu B; Smit TK
    Vaccine; 2010 Sep; 28(39):6505-17. PubMed ID: 20638456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the immunoenzyme test ELISA-NS3 to distinguish horses infected by African horsesickness virus from vaccinated horses].
    Idrissi Bougrine S; Fassi Fihri O; el Harrak M; Fassi Fehri MM
    Rev Sci Tech; 1999 Dec; 18(3):618-26. PubMed ID: 10588005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive transfer and rate of decay of maternal antibody against African horse sickness virus in South African Thoroughbred foals.
    Crafford JE; Lourens CW; Gardner IA; Maclachlan NJ; Guthrie AJ
    Equine Vet J; 2013 Sep; 45(5):604-7. PubMed ID: 23294121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses.
    Dennis SJ; O'Kennedy MM; Rutkowska D; Tsekoa T; Lourens CW; Hitzeroth II; Meyers AE; Rybicki EP
    Vet Res; 2018 Oct; 49(1):105. PubMed ID: 30309390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
    Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
    Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
    Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control and eradication of African horse sickness with vaccine.
    Sánchez-Vizcaíno JM
    Dev Biol (Basel); 2004; 119():255-8. PubMed ID: 15742636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
    El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine.
    House JA; Lombard M; Dubourget P; House C; Mebus CA
    Vaccine; 1994 Feb; 12(2):142-4. PubMed ID: 8147096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future international management of African horse sickness vaccines.
    House JA
    Arch Virol Suppl; 1998; 14():297-304. PubMed ID: 9785514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and differentiation of the nine African horse sickness virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.
    Sailleau C; Hamblin C; Paweska JT; Zientara S
    J Gen Virol; 2000 Mar; 81(Pt 3):831-7. PubMed ID: 10675421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on antibody levels associated with active and passive immunity to African horse sickness.
    Blackburn NK; Swanepoel R
    Trop Anim Health Prod; 1988 Nov; 20(4):203-10. PubMed ID: 3238767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for African horse sickness vaccines for use in nonendemic areas.
    House JA
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):77-81. PubMed ID: 8134660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.